STAT+: New tumor cases show common gene therapy tool can come with risk
Newly reported cases indicate that AAV gene therapies such as Zolgensma can carry tumor risks, raising key concerns for SMA patients and for gene therapy researchers in general.
AI summary · generated only from source feed metadata; consult originalSource published
Published here
views1
Original source
STAT — Biotech
Media report · consult original reporting
Read the original ↗https://www.statnews.com/2026/11/06/novartis-zolgensma-gene-therapy-tumor-risk/Original headline
STAT+: New tumor cases show common gene therapy tool can come with risk
AI bilingual edit · consult originalHeadlines are indexed or machine translated, not independent verification of scientific results. Medical news is not clinical advice. Distinguish interstellar concepts from demonstrated space technology using the original source.